Remove business banking
article thumbnail

Cigna explores selling Medicare Advantage business: report

Fierce Healthcare

Cigna is looking into the possibility of selling its Medicare Advantage (MA) business, according to a report from Reuters. Cigna may decide to sell off its Medicare Advantage business. The insurer is reportedly in early discussions with an investment bank to go over its options.

Insurance 118
article thumbnail

Headspace banks $105M in new financing as it eyes potential M&A and expansion of enterprise business

Fierce Healthcare

Digital mental health company Headspace secured $105 million in new debt financing as it eyes opportunities to expand its business with employers and health plans.

98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Morgan Health wants you to know it’s still here

STAT

SAN FRANCISCO  — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

Insurance 107
article thumbnail

Newsletter – April 2024

Fuld

Discover how boutique investment banks are leveraging research and analytics to close deals faster. Read about our recent strategy workshop with a metal manufacturer, where we helped them identify and evaluate new growth opportunities. Learn more about Shell’s significant strategy shift in the energy sector.

52
article thumbnail

STAT+: SVB, biotech’s bank of choice, just failed. It could have ripple effects

STAT

Silicon Valley Bank, which does business with roughly half of the nation’s tech and biotech companies, failed on Friday. Now, as federal regulators step in to clean up SVB’s mess, biotech startups are left wondering: What happens to their money, and who’s going to finance the industry?

Insurance 145
article thumbnail

Newsletter – March 2024

Fuld

This month, catch up on how we’re extending our support for boutique investment banks through our Finalis partnership, and sign up for our essential webinar on dealmaking tools. Read more Why is Shell shifting its hydrogen strategy?

52
article thumbnail

Biopharma could reap benefits from SVB UK acquisition

European Pharmaceutical Review

Following the collapse of Silicon Valley Bank (SVB), HSBC’s acquisition of Silicon Valley Bank (SVP) UK may offer new opportunities for biopharmaceutical companies, according to data and analytics firm, GlobalData. A Danish pharma company developing peptide-based medicines, expects to recover its $23.4 million in deposits.

89